• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CeriBell, Inc. - Common Stock (NQ:CBLL)

23.49 -0.46 (-1.92%)
Streaming Delayed Price Updated: 1:34 PM EDT, Aug 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CeriBell, Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
CeriBell Expands EEG Platform Beyond Seizures With Delirium, Pediatric Push ↗
August 12, 2026
CeriBell (NASDAQ:CBLL) outlined its plans to expand its brainwave-monitoring platform beyond seizure detection, pointing to new products for delirium, pediatric patients and eventually stroke as it... 
Via MarketBeat
News headline image
CeriBell (CBLL) Q2 2026 Earnings Call Transcript ↗
August 10, 2026
Revenue surged 33% as hospital accounts expanded and delirium reimbursement neared launch. 
Via The Motley Fool
Topics Earnings Intellectual Property World Trade
News headline image
CeriBell Q2 Earnings Call Highlights ↗
August 10, 2026
CeriBell (NASDAQ:CBLL) reported second-quarter 2026 revenue growth of 33% as increased utilization at existing hospital accounts and continued customer additions supported results. The company also... 
Via MarketBeat
Topics Earnings World Trade
Ceribell Inc (NASDAQ:CBLL) Q1 Revenue Beats Estimates, Net Loss Widens, Full-Year Guidance Raised ↗
May 11, 2026
Via Chartmill
Ceribell Inc (NASDAQ:CBLL) Reports Strong Q4 Revenue Beat and Provides 2026 Outlook ↗
February 24, 2026
Via Chartmill
News headline image
Ceribell Reports Second Quarter 2026 Financial Results
August 10, 2026
From Ceribell
Via GlobeNewswire
News headline image
Ceribell Receives FDA Clearance for Advanced Epileptiform Abnormality Detection and Artifact Reduction for Its Cloud-Based Portal, Delivering Greater Precision for Critical-Care EEG Review
August 10, 2026
Neurology Review Software Enhancements Included as Part of Industry-Leading Ceribell Point-of-Care Brain Monitoring System 
From Ceribell
Via GlobeNewswire
News headline image
Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor System
August 03, 2026
Incremental NTAP Reimbursement Stands to Broaden Access to First-of-Its-Kind Dual Seizure and Delirium Monitoring Platform 
From Ceribell
Via GlobeNewswire
News headline image
Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O’Keefe
July 29, 2026
Medtech Market-Builder Thomas West and Health System Operator Sharon O’Keefe Join Ceribell as Point-of-Care Brain Monitoring Advances Toward Standard of Care 
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Participate in the Canaccord Genuity 46th Annual Growth Conference
July 28, 2026
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Report Second Quarter 2026 Financial Results on August 10, 2026
July 20, 2026
From Ceribell
Via GlobeNewswire
News headline image
Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes
June 08, 2026
Study published in leading critical care journal shows that higher AI-detected seizure burden is associated with increased odds of disability, further demonstrating the utility of the Ceribell System... 
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference
May 20, 2026
From Ceribell
Via GlobeNewswire
News headline image
CeriBell Sees ‘Early Innings’ Growth as Hospital Accounts and Usage Hit Records ↗
May 15, 2026
CeriBell (NASDAQ:CBLL) executives said the company’s first-quarter results reflected continued momentum in both new account additions and increased usage among existing hospital customers, while... 
Via MarketBeat
News headline image
CeriBell Q1 Earnings Call Highlights ↗
May 11, 2026
CeriBell (NASDAQ:CBLL) reported first-quarter revenue growth of 29% and raised its full-year outlook, as management cited higher usage of its seizure monitoring system and the company’s strongest... 
Via MarketBeat
Topics Earnings
News headline image
CeriBell (CBLL) Q1 2026 Earnings Transcript ↗
May 11, 2026
CeriBell (CBLL) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics World Trade
News headline image
Ceribell Reports First Quarter 2026 Financial Results
May 11, 2026
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Participate in the Bank of America Securities 2026 Health Care Conference
April 29, 2026
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Report First Quarter 2026 Financial Results on May 11, 2026
April 20, 2026
From Ceribell
Via GlobeNewswire
News headline image
CeriBell (CBLL) Q4 2025 Earnings Call Transcript ↗
February 24, 2026
CeriBell (CBLL) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings World Trade
News headline image
Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results
February 24, 2026
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Participate in Upcoming March Investor Conferences
February 18, 2026
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
February 10, 2026
From Ceribell
Via GlobeNewswire
News headline image
Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution
January 05, 2026
Clearance would position the Ceribell System as the first and only point-of-care electroencephalography (EEG) technology to aid in detection and monitoring of Large Vessel Occlusion (LVO) stroke in the... 
From Ceribell
Via GlobeNewswire
News headline image
AI Diagnostics: The End of the High-Cost Imaging Era
January 16, 2026
Issued on behalf of VentriPoint Diagnostics Ltd. 
From Equity Insider
Via GlobeNewswire
News headline image
Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference
December 30, 2025
From Ceribell
Via GlobeNewswire
News headline image
Global AI Infrastructure Shift Ignites Biotech Growth Phase
December 09, 2025
From USA News Group
Via GlobeNewswire
News headline image
Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution
December 09, 2025
Novel technology paves the way for use of the company's industry-leading point-of-care electroencephalography (EEG) system to address long unmet need in delirium monitoring 
From Ceribell
Via GlobeNewswire
News headline image
Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates
November 24, 2025
Becomes the first and only FDA-cleared seizure detection algorithm for pre-term neonates through adults enabling rapid bedside detection, diagnosis, and treatment of non-convulsive seizures 
From Ceribell
Via GlobeNewswire
News headline image
Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference
November 19, 2025
From Ceribell
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap